Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.55 |
| ▸ | CA2 | P00918 | 6/20 | 0.55 |
| ▸ | CA9 | Q16790 | 6/20 | 0.55 |
| ▸ | CA12 | O43570 | 5/20 | 0.55 |
| ▸ | CA7 | P43166 | 5/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.55 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.55 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3422644 | 0.89 | CA12 (0.54) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3761829 | 0.86 | CA12 (0.53) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2590792 | 0.86 | CA12 (0.53) | CA1CA2CA9CA12CA7 | |
| SCHEMBL30466430 | 0.86 | CA12 (0.53) | CA1CA2CA9CA12CA7 | |
| SCHEMBL12553221 | 0.84 | CA12 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2456583 | 0.83 | MEN1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL24820610 | 0.82 | CA12 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL30966098 | 0.82 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL25475896 | 0.82 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL21438533 | 0.82 | CA1 (0.50) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | claimed |
| US-20260138990-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4702026-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | Aeovian Pharmaceuticals, Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-12421452-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| WO-2024226685-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | disclosed |
| US-20240084196-A1 | METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER PROCESSED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11884864-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-117257779-A | Phloroglucinol compound injection | 康普药业股份有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-20220204853-A1 | METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER PROCESSED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2022-06-30 | — | — | US | disclosed |
| US-20100316555-A1 | PROCESS FOR PRODUCING CARBON | Sumitomt Chemical Company, Limited (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100029631-A1 | CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-7601712-B2 | Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
| US-20070004716-A1 | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| EP-1666473-A1 | CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-06-07 | — | — | EP | disclosed |
| CN-1257886-C | Dehydroamino acids compounds | HOFFMANN LA ROCHE (CH) | 2006-05-31 | — | — | CN | disclosed |
| EP-1317241-A2 | SHAMPOO COMPOSITIONS WITH CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2003-06-11 | — | — | EP | disclosed |
| CN-1398252-A | dehydroamino acid compounds | HOFFMANN LA ROCHE (CH) | 2003-02-19 | — | — | CN | disclosed |
| WO-2002022091-A2 | SHAMPOO COMPOSITIONS WITH CATIONIC POLYMERS | PROCTER & GAMBLE COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| US-20020012646-A1 | Shampoo compositions with cationic polymers | PROCTER & GAMBLE COMPANY, THE | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138990-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | CD38, BCL9, BCL6B | CA1 789/4885CA2 187/4885CA9 73/4885 |
| US-20100029631-A1 | CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | GPR17, CYSLTR1, KIT | CA1 542/4885CA2 374/4885CA9 1505/4885 |
| US-20020012646-A1 | Shampoo compositions with cationic polymers | S100P, PSAP, PHOSPHO1 | CA1 1620/4885CA2 818/4885CA9 3022/4885 |
| US-20070004716-A1 | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | GPR17, CYSLTR1, KIT | CA1 542/4885CA2 374/4885CA9 1505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.